Early Eculizumab Treatment Improves Outcomes in Atypical HUSEarly Eculizumab Treatment Improves Outcomes in Atypical HUS

Rapid diagnosis and early initiation of eculizumab helps patients with atypical hemolytic uremic syndrome (HUS) recover normal renal function, a new analysis shows. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news